Details of the Drug
General Information of Drug (ID: DM728RW)
Drug Name |
BLX-301
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | Glyco-optimized rituximab; Anti-CD20 antibody (LEX, non-Hodgkin lymphoma); Anti-CD20 antibody (non-Hodgkin lymphoma), EPIcyte; Anti-CD20 antibody (LEX, non-Hodgkin lymphoma), Biolex | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Antibody
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||